DNA immunization of the grafted liver by particle-mediated gene gun

被引:8
作者
Nakamura, M
Wang, J
Murakami, T
Ajiki, T
Hakamata, Y
Kaneko, T
Takahashi, M
Okamoto, H
Mayumi, M
Kobayashi, E
机构
[1] Jichi Med Sch, Div Organ Replacement Res, Ctr Mol Med, Minamimaki, Tochigi 3290498, Japan
[2] Jichi Med Sch, Anim Resource Project, Ctr Mol Med, Minamimaki, Tochigi 3290498, Japan
关键词
D O I
10.1097/01.TP.0000091118.22413.E1
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Direct DNA vaccination of liver allografts before transplantation may provide an effective strategy for inducing protective immunity to infection and malignancy. Methods. In this study, the authors examined the feasibility of gene gun-mediated vaccination of liver grafts. Using plasmids expressing luciferase and green fluorescent proteins, their expression was tested in a graft liver. Results. Protein expression was observed in the graft liver and significantly enhanced in hepatectomized rats. A short course of tacrolimus (FK506) also evoked the expression of these proteins. Effects of primary immunization to the liver on the humoral response were then tested using an expression plasmid encoding hepatitis B virus surface (HBs) antigen and were compared to that of skin immunization alone. The results showed that local immunization to the liver strongly induced antibody formation. Furthermore, the combination of an immunized partial liver graft with tacrolimus significantly enhanced antibody production against HBs antigen. Conclusions. A DNA vaccine to the liver may be one strategy for preventing infectious disease associated with liver transplantation under tacrolimus treatment.
引用
收藏
页码:1369 / 1375
页数:7
相关论文
共 21 条
  • [1] Long-lasting gene expression by particle-mediated intramuscular transfection modified with bupivacaine: combinatorial gene therapy with IL-12 and IL-18 cDNA against rat sarcoma at a distant site
    Ajiki, T
    Murakami, T
    Kobayashi, Y
    Hakamata, Y
    Wang, J
    Inoue, S
    Ohtsuki, M
    Nakagawa, H
    Kariya, Y
    Hoshino, Y
    Kobayashi, E
    [J]. CANCER GENE THERAPY, 2003, 10 (04) : 318 - 329
  • [2] Adenovirus-mediated gene transfer to liver grafts - An improved method to maximize infectivity
    Chia, SH
    Geller, DA
    Kibbe, MR
    Watkins, SC
    Fung, JJ
    Starzl, TE
    Murase, N
    [J]. TRANSPLANTATION, 1998, 66 (11) : 1545 - 1551
  • [3] Corales R, 2000, Transpl Infect Dis, V2, P133, DOI 10.1034/j.1399-3062.2000.020306.x
  • [4] Protection against Plasmodium falciparum malaria in chimpanzees by immunization with the conserved preerythrocytic liver-stage antigen 3
    Daubersies, P
    Thomas, AW
    Millet, P
    Brahimi, K
    Langermans, JAM
    Ollomo, B
    Ben Mohamed, L
    Slierendregt, B
    Eling, W
    Van Belkum, A
    Dubreuil, G
    Meis, JFGM
    Guérin-Marchand, C
    Cayphas, S
    Cohen, J
    Gras-Masse, H
    Druilhe, P
    [J]. NATURE MEDICINE, 2000, 6 (11) : 1258 - 1263
  • [5] FRANCAVILLA A, 1989, LANCET, V2, P1248
  • [6] Prevention of recurrence of hepatitis B virus infection after liver transplantation
    Fueyo, AS
    [J]. BIODRUGS, 2000, 13 (03) : 189 - 194
  • [7] DNA vaccines: Immunology, application, and optimization
    Gurunathan, S
    Klinman, DM
    Seder, RA
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 2000, 18 : 927 - 974
  • [8] KIM YI, 1992, TRANSPLANTATION, V53, P949
  • [9] KIM YI, 1988, SURG GYNECOL OBSTET, V166, P317
  • [10] SUPPRESSION OF ALLOGRAFT-REJECTION WITH FK506 .1. PROLONGED CARDIAC AND LIVER SURVIVAL IN RATS FOLLOWING SHORT-COURSE THERAPY
    MURASE, N
    KIM, DG
    TODO, S
    CRAMER, DV
    FUNG, JJ
    STARZL, TE
    [J]. TRANSPLANTATION, 1990, 50 (02) : 186 - 189